Relaxo Footwears Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2025.
RELAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.2 pts less than its Footwear peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Relaxo Footwears reported its FY25 audited results, with annual revenue from operations declining to ₹2,789.61 cr from ₹2,914.06 cr in FY24, a drop of about 4.3%. Profit after tax fell to ₹170.33 cr from ₹200.47 cr, down roughly 15%. Q4 FY25 revenue was ₹695.15 cr versus ₹747.21 cr in Q4 FY24, with Q4 PAT at ₹56.22 cr versus ₹61.39 cr. EBITDA margins compressed by about 120 basis points year-on-year as cost pressures weighed on profitability. The board recommended a final dividend of ₹3 per share (300% of face value), totaling ₹74.68 cr. The statutory auditors M/s Gupta & Dua issued an unmodified opinion on the financial statements, indicating no qualifications or concerns.
Negative for shareholders in the short term — both top-line and bottom-line contracted year-on-year, and margins shrank, though the company remains debt-free with strong operating cash flows of ₹406 cr and a healthy dividend payout. The clean audit report and zero borrowings provide stability, but the topline decline signals demand or pricing pressure that investors will watch closely.